PEDOT: PSS for Implantable and Wearable Bioelectronics: From Material Engineering and Energy Storage to Clinical Translation
Small · 2026-07 · 22 (41)
DOI: 10.1002/smll.74167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 12.06.2026. Verfasst von Zekun Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Medical Devices, Shenyang Pharmaceutical University, Shenyang, China. Hauptthemen laut MEDLINE: Polystyrenes, Bridged Bicyclo Compounds, Heterocyclic, Polymers, Wearable Electronic Devices. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, Liaoning Province Revitalization Talent Program.
Abstract (Originalsprache)
Poly(3,4‐ethylenedioxythiophene): polystyrene sulfonate (PEDOT: PSS), distinguished by its exceptional electrical conductivity, superior biocompatibility, and capacity for multifunctional integration, has emerged as a pivotal biomaterial at the nexus of biomedical engineering and flexible electronics. This review systematically elucidates the fundamental physicochemical attributes and charge transport mechanisms of PEDOT: PSS. It critically examines mainstream modification strategies—including solvent doping, surfactant engineering, nanocomposite formulation, and plasma treatment—providing deep insights into how these approaches govern the material's microstructure and macroscopic performance. Building on this foundation, we detail recent breakthroughs in frontier applications such as biosensing and real‐time monitoring, electroceuticals, tissue engineering and regenerative medicine, smart targeted drug delivery, and self‐powered wearable devices. Special emphasis is placed on the synergistic interplay among performance optimization, modification strategies, and clinical translation. Furthermore, the article offers a critical analysis of persistent challenges hindering clinical adoption, including long‐term stability, biosafety, and batch‐to‐batch consistency. Finally, we outline future trajectories, such as counterion substitution, biomimetic interface functionalization, and intelligent closed‐loop systems. This work aims to establish a robust theoretical and technical framework to accelerate the advanced research and broad deployment of PEDOT: PSS in biomedical contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, School of Medical Devices, Shenyang Pharmaceutical University, Shenyang, China.
- Vita Tech Innovation Center, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China.
- School of Biomedical Engineering, Tsinghua University, Beijing, China.
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- Liaoning Province Revitalization Talent Program
- Natural Science Foundation of Liaoning Province
- Scientific Research Projects of Liaoning Provincial Department of Education
- National Key Research and Development Program of China
Zitieren
APA
Ma, Z., Zhang, Y., Li, Z., Meng, Z., & Lian, H. (2026). PEDOT: PSS for Implantable and Wearable Bioelectronics: From Material Engineering and Energy Storage to Clinical Translation. Small, 22(41). https://doi.org/10.1002/smll.74167
Vancouver
Ma Z, Zhang Y, Li Z, Meng Z, Lian H. PEDOT: PSS for Implantable and Wearable Bioelectronics: From Material Engineering and Energy Storage to Clinical Translation. Small. 2026;22(41). doi:10.1002/smll.74167
BibTeX
@article{Ma2026,
author = {Ma, Zekun and Zhang, Ying and Li, Zhou and Meng, Zhaoxu and Lian, He},
title = {PEDOT: PSS for Implantable and Wearable Bioelectronics: From Material Engineering and Energy Storage to Clinical Translation},
journal = {Small},
year = {2026},
volume = {22},
number = {41},
doi = {10.1002/smll.74167}
}
EUVIMED